Concepedia

Dan H. Moore

DH

Statistics

Publications

388

Citations

31.4K

H-Index

96

Active since

1940

Affiliations

University of California, San Francisco(Current)

California Pacific Medical Center

Columbia University

Lawrence Livermore National Laboratory

Coriell Institute For Medical Research

Dan H. Moore is an author at University of California, San Francisco specializing in medicine, oncology, and life sciences.

ORCID

Publications per year

1940–2023

388

Publications

388

Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma

Noel Weidner, J Folkman, F. Pozza et al. · JNCI Journal of the National Cancer Institute · 1992 · 1.8K citations

, , +14

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Robert G. Miller, John D. Mitchell, Dan H. Moore · Cochrane Database of Systematic Reviews · 2012 · 1K citations · Full text

, , +13

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

Ann D. Thor, Dan H. Moore, S M Edgerton et al. · JNCI Journal of the National Cancer Institute · 1992 · 733 citations

, , +12

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

John W. Park, Keelung Hong, Dmitri B. Kirpotin et al. · PubMed · 2002 · 648 citations · Full text

, , +17

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

Dan H. Moore, Robert G. Miller, Julaine Florence et al. · The Lancet Neurology · 2007 · 642 citations

, , +10

1–5 of 388